$15,000 of AXOGEN INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues relating to sensation loss after mastectomy."
You can find more data on corporate lobbying on Quiver Quantitative.
AXGN Insider Trading Activity
AXGN insiders have traded $AXGN stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $AXGN stock by insiders over the last 6 months:
- WILLIAM P. MR. BURKE has made 0 purchases and 10 sales selling 96,940 shares for an estimated $1,913,506.
- JOSEPH A. TYNDALL has made 0 purchases and 4 sales selling 49,518 shares for an estimated $542,760.
- GUIDO J NEELS sold 4,073 shares for an estimated $43,214
- AMY MCBRIDE WENDELL sold 4,073 shares for an estimated $43,214
- JOHN JOHNSON sold 4,073 shares for an estimated $43,214
- ALAN M LEVINE sold 4,073 shares for an estimated $43,214
- KATHY JOHNSON WEILER sold 4,073 shares for an estimated $43,214
- ERICK WAYNE DEVINNEY (Chief Innovation Officer) sold 1,137 shares for an estimated $18,521
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AXGN Hedge Fund Activity
We have seen 89 institutional investors add shares of AXGN stock to their portfolio, and 83 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALYASNY ASSET MANAGEMENT L.P. added 1,250,968 shares (+183.9%) to their portfolio in Q2 2025, for an estimated $13,573,002
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 1,172,029 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,716,514
- BESSEMER GROUP INC added 810,951 shares (+inf%) to their portfolio in Q3 2025, for an estimated $14,467,365
- WASATCH ADVISORS LP added 659,149 shares (+85.1%) to their portfolio in Q2 2025, for an estimated $7,151,766
- BROWN CAPITAL MANAGEMENT LLC added 644,623 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,500,074
- ARMISTICE CAPITAL, LLC added 573,041 shares (+106.5%) to their portfolio in Q2 2025, for an estimated $6,217,494
- NICHOLAS INVESTMENT PARTNERS, LP removed 414,281 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,494,948
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AXGN Analyst Ratings
Wall Street analysts have issued reports on $AXGN in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 10/30/2025
- Citizens issued a "Market Outperform" rating on 10/30/2025
- Raymond James issued a "Outperform" rating on 10/30/2025
- HC Wainwright & Co. issued a "Buy" rating on 10/30/2025
To track analyst ratings and price targets for AXGN, check out Quiver Quantitative's $AXGN forecast page.
AXGN Price Targets
Multiple analysts have issued price targets for $AXGN recently. We have seen 4 analysts offer price targets for $AXGN in the last 6 months, with a median target of $27.0.
Here are some recent targets:
- Caitlin Cronin from Canaccord Genuity set a target price of $27.0 on 10/30/2025
- David Turkaly from Citizens set a target price of $34.0 on 10/30/2025
- Yi Chen from HC Wainwright & Co. set a target price of $26.0 on 10/30/2025
- Jayson Bedford from Raymond James set a target price of $27.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
